A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The pathogenesis of diabetic cardiomyopathy is unknown. The synergistic, or enhanced, effect of hypertension on pathological changes in the heart of diabetic patients has been highly suspected. The purpose of this study was to evaluate the myocardial changes related to diabetes mellitus with and without hypertension, using biopsy specimens. We examined the ultrastructural changes in biopsy specimens of the endomyocardium obtained from 25 patients. They were divided into four groups: controls without hypertension or diabetes mellitus (n = 6), and patient with hypertension (n = 3), diabetes mellitus (n = 8), and diabetes with hypertension (n = 8). The diabetic patients showed nearly normal or mildly depressed systolic left ventricular function. Ultrastructural pictures were analyzed for thickening of the capillary basement membrane, presence of toluidine blue-positive materials (i.e., materials showing metachromasia) in the myocytes, size of myocytes, and interstitial fibrosis. The thickening of the capillary basement membrane, the accumulation of toluidine blue-positive materials, and interstitial fibrosis were all significantly greater in the patients with diabetes mellitus compared to the control subjects. The myocytes tended to be small (cell atrophy) in the diabetes group. Although these pathological changes in the heart were characteristic of diabetic patients, irrespective of the presence or absence of hypertension, the presence of hypertension increased the pathological changes of myocardial cells as well as abnormality in the capillary vessels in patients with diabetes mellitus. Alterations in the myocardial cells and capillaries, caused by diabetes mellitus, may lead to myocardial cell injury and interstitial fibrosis and, ultimately, to ventricular systolic and diastolic dysfunction, especially when the diabetes is accompanied by hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T2D patients are also at increased risk of heart failure due to diabetic cardiomyopathy, where myocardial disease manifests in the absence of any other known CVD, likely due to hyperglycemia, microvascular damage and autonomic neuropathy associated with diabetes.232,239”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [239]
Citations
Cites
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090 · cited 2×
“In addition, ultrastructural changes of the myocytes, interstitium and capillaries, which might occur in diabetics, and modifications due to the presence of hypertension, have not been clarified in previous studies [ 1-5 ].”
BackgroundResultNew type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Evidence for Cardiomyopathy in Familial Diabetes Mellitus
Regan, T. J., Lyons, M. M., Ahmed, S. S., Levinson, G. E., Oldewurtel, H. A., Ahmad, M. R., & Haider, B. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108843 · Cited by 728 · cited 1×
“The pathogenesis of this cardiomyopathy is unknown, but proposed mechanisms include small vessel (intramural) coronary artery disease [1, 3-5], interstitial myocardial accumulation of glycoprotein and collagen [ 6 ], and metabolic alterations of the diabetic myocardium [7, 8].”
BackgroundSiperstein, M. D., Unger, R. H., & Madison, L. L. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105886 · Cited by 592
Microvascular distribution of coronary vascular resistance in beating left ventricle
Chilian, W. M., Eastham, C. L., & Marcus, M. L. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.251.4.h779 · Cited by 378
van Hoeven, K. H., & Factor, S. M. (1990) · Circulation · doi:10.1161/01.cir.82.3.848 · Cited by 342
Hamby, R. I. (1974) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1974.03230510023016 · Cited by 301
Capillary Microaneurysms in the Human Diabetic Heart
Factor, S. M., Okun, E. M., & Minase, T. (1980) · New England Journal of Medicine · doi:10.1056/nejm198002143020706 · Cited by 283 · cited 2×
“They suggested that the combined effects of diabetes mellitus and hypertension increase the alterations in myocardial contractility, leading to a specific abnormality of the heart muscle of hypertensive diabetic patients, or to hypertensivediabetic cardiomyopathy [ 10-12 ].”
BackgroundResultAltered Myocardial Function and Metabolism in Chronic Diabetes Mellitus without Ischemia in Dogs
REGAN, T. J., ETTINGER, P. O., KHAN, M. I., JESRANI, M. U., LYONS, M. M., OLDEWURTEL, H. A., & WEBER, M. (1974) · Circulation Research · doi:10.1161/01.res.35.2.222 · Cited by 276
Clinical and morphological features of human hypertensive-diabetic cardiomyopathy
Factor, S. M., Minase, T., & Sonnenblick, E. H. (1980) · American Heart Journal · doi:10.1016/0002-8703(80)90379-8 · Cited by 235
Research works printed but not linked: 3
- Blunmental HT, Alex M, Goldenberg S (1960) A study of lesions of intramural coronary by branches in diabetes mellitus. Arch Pathol 70:27–42
- Rudolf V (1974) Basal lamina layering in diabetes mellitus. Diabetes 23:94–104
- Kenneth HG, O’Sullivan JB (1988) The sorbitol pathway. Diabetes 17:239–243
Cited by
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0012 · Cited by 912
Russo, I., & Frangogiannis, N. G. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.011 · Cited by 474
Diabetic cardiomyopathy: pathophysiology and clinical features
Miki, T., Yuda, S., Kouzu, H., & Miura, T. (2013) · Heart Failure Reviews · doi:10.1007/s10741-012-9313-3 · Cited by 460
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Oxidative Stress and Diabetic Cardiomyopathy: A Brief Review
Cai, L., & Kang, Y. J. (2001) · Cardiovascular Toxicology · doi:10.1385/ct:1:3:181 · Cited by 376
“These pathological conditions may affect the diabetic heart to varying degrees; however, hypertension is definitely a cocontributor to diabetic cardiomyopathy (3,39,41,42).”
BackgroundDiffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 361
Diabetic cardiomyopathy - A comprehensive updated review
Murtaza, G., Virk, H. U. H., Khalid, M., Lavie, C. J., Ventura, H., Mukherjee, D., Ramu, V., Bhogal, S., Kumar, G., Shanmugasundaram, M., et al. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.03.003 · Cited by 358
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
HAYAT, S. A., PATEL, B., KHATTAR, R. S., & MALIK, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 352
The Pathophysiology of Cardiovascular Disease and Diabetes: Beyond Blood Pressure and Lipids
Dokken, B. B. (2008) · Diabetes Spectrum · doi:10.2337/diaspect.21.3.160 · Cited by 299
Diastolic Dysfunction and Diabetic Cardiomyopathy
Galderisi, M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.033 · Cited by 279
Sorop, O., Heinonen, I., van Kranenburg, M., van de Wouw, J., de Beer, V. J., Nguyen, I. T. N., Octavia, Y., van Duin, R. W. B., Stam, K., van Geuns, R.-J., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy038 · Cited by 208
“The lack of myocyte hypertrophy, is in agreement with the maintained PKG activity levels in our animals and in accordance with the concept that severe hyperglycemia induces muscle cell atrophy both in skeletal(39,40) and cardiac muscle.(41,42) Furthermore, myocyte size inversely correlated in our animals with the leve…”
ResultVoulgari, Tentolouris, N., & Papadogiannis, D. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s11681 · Cited by 210
“The Framingham Study demonstrated that the determination of LV hypertrophy electrocardiographically was not associated significantly with increased cardiovascular morbidity and mortality.(25) However, in the Framingham Study, when LV hypertrophy was assessed echocardiographically in a population of 3,222 patients, it…”
Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes
Grisanti, L. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01669 · Cited by 174
“, 1989 and type 2 diabetes (Regan et al., 1977; Fischer et al., 1984; Nunoda et al., 1985; van Hoeven and Factor, 1990; Shimizu et al., 1993; Kawaguchi et al., 1997) however, the contribution of fibrosis to atrial fibrillation is not fully understood in the context of diabetes.”
BackgroundTargeting Fibrosis for the Treatment of Heart Failure: A Role for Transforming Growth Factor‐β
Edgley, A. J., Krum, H., & Kelly, D. J. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00228.x · Cited by 149
Diabetic cardiomyopathy: Pathophysiological mechanisms and cardiac dysfuntion
Goyal, B., & Mehta, A. U. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327112450885 · Cited by 118
“The combination of cell loss and slowly decreasing contractility resulting from the reactive hypertrophy due to a compensatory response to myocellular necrosis culminates in a cardiomyopathy.70 Kawaguchi et al.71 carried out a biopsy study and reported that diabetic patients had nearly normal or mildly depressed systo…”
BackgroundStructural changes in the myocardium during diabetes-induced cardiomyopathy
Adeghate, E. A., & Singh, J. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9388-5 · Cited by 112
Ares-Carrasco, S., Picatoste, B., Benito‐Martín, A., Zubiri, I., Sanz, A. B., Sánchez-Niño, M. D., Ortíz, A., Egido, J., Tuñón, J., & Lorenzo, Ó. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00157.2009 · Cited by 104
Solomon, S. D., Sutton, M. S. J., Lamas, G. A., Plappert, T., Rouleau, J. L., Skali, H., Moyé, L., Braunwald, E., & Pfeffer, M. A. (2002) · Circulation · doi:10.1161/01.cir.0000032313.82552.e3 · Cited by 102
Farhangkhoee, H., Khan, Z. A., Kaur, H., Xin, X., Chen, S., & Chakrabarti, S. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.008 · Cited by 108
Kasznicki, J., & Drzewoski, J. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.43748 · Cited by 84
Pan, K., Hsu, Y., Chang, S., Chung, C., & Lin, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108604 · Cited by 90
“DM leads to myocardial cell injury, interstitial fibrosis, and, ultimately, ventricular systolic and diastolic dysfunction, which mediate diabetic cardiomyopathy to become HFpEF clinically [44].”
BackgroundLi, P., & Fan, H. (2023) · Cells · doi:10.3390/cells12151931 · Cited by 85
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Karwi, Q. G., Ho, K. L., Pherwani, S., Ketema, E. B., Sun, Q., & Lopaschuk, G. D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab120 · Cited by 90
Diabetes and the Risk of Heart Failure
Dhingra, R., & Vasan, R. S. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.08.008 · Cited by 82
Moir, S., Hanekom, L., Fang, Z.-Y., Haluska, B. A., Wong, C. Y., Burgess, M. I., & Marwick, T. H. (2006) · Heart · doi:10.1136/hrt.2005.079350 · Cited by 75
“The precise aetiology of diabetic myocardial disease remains controversial, with potential contributions from microvascular disease, direct metabolic effects on the myocyte and fibrosis. The similar pathology of diabetic renal disease often leads to an expectation that vascular disease may be a primary underlying feat…”
BackgroundAnnonu, A. K. M. H., Fattah, A. A., Mokhtar, M. S., Ghareeb, S., & Elhendy, A. (2001) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2001.112892 · Cited by 75
Timmer, J. R., van der Horst, I. C. C., Luca, G. D., Ottervanger, J. P., Hoorntje, J. C. A., de Boer, M., Suryapranata, H., Dambrink, J. E., Gosselink, M., Zijlstra, F., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.088 · Cited by 74
Bloomgarden, Z. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1506 · Cited by 86
Joshi, M., Kotha, S. R., Malireddy, S., Selvaraju, V., Satoskar, A. R., Palesty, A., McFadden, D. W., Parinandi, N. L., & Maulik, N. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1861-x · Cited by 71
“If diabetes coexists with hypertension, the pathological changes observed in myocardium including thickening of the capillary basement membrane, interstitial fibrosis, and cell atrophy are amplified [51].”
BackgroundDiabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?
Mizamtsidi, M., Paschou, S. Α., Grapsa, J., & Vryonidou, A. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12673 · Cited by 75
Galderisi, M., Capaldo, B., Sidiropulos, M., D’Errico, A., Ferrara, L. A., Turco, A., Guarini, P., Riccardi, G., & Dedivitiis, O. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.08.005 · Cited by 68
Exercise Attenuates Diabetes-Induced Ultrastructural Changes in Rat Cardiac Tissue
Searls, Y. M., Smirnova, I. V., Fegley, B., & Stehno‐Bittel, L. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000145461.38224.ec · Cited by 66
Left Ventricular Dysfunction and Remodeling in Streptozotocin-Induced Diabetic Rats
Nemoto, O., Kawaguchi, M., Yaoita, H., Miyake, K., Maehara, K., & Maruyama, Y. (2006) · Circulation Journal · doi:10.1253/circj.70.327 · Cited by 65
Self-citationMorphological characteristics in diabetic cardiomyopathy associated with autophagy
Kanamori, H., Naruse, G., 吉田明弘, Minatoguchi, S., Watanabe, T., Kawaguchi, T., Tanaka, T., Yamada, Y., Takasugi, H., Mikami, A., et al. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.05.009 · Cited by 65
Campbell, D. J., Somaratne, J. B., Jenkins, A. J., Prior, D. L., Yii, M., Kenny, J. F., Newcomb, A. E., Schalkwijk, C. G., Black, M. J., & Kelly, D. J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-80 · Cited by 64
“There are reports of increased interstitial fibrosis and collagen deposition [12-16], and reports of no difference in fibrosis between diabetic and non-diabetic hearts [17-19], although the impact of diabetes on fibrosis may depend on concomitant hypertension [18].”
BackgroundBajraktari, G., Koltai, M. Z., Ademaj, F., Rexhepaj, N., Qirko, S., Ndrepepa, G., & Elezi, S. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.08.033 · Cited by 63
Zhao, C. T., Wang, M., Siu, C., Hou, Y., Wang, T., Tse, H., & Yiu, K. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-147 · Cited by 61
“The presence of diabetes induces thickening of the capillary basement membrane and endothelial swelling of the myocardium [26,27].”
BackgroundLongitudinal Changes in Left Ventricular Diastolic Function in a General Population
Kuznetsova, T., Thijs, L., Knez, J., Cauwenberghs, N., Petit, T., Gu, Y., Zhang, Z., & Staessen, J. A. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.002882 · Cited by 65
“Microvascular damage may lead to myocardial cell injury and reactive fibrosis/hypertrophy.(21) Our study has to be interpreted within the context of its potential limitations and strengths.”
BackgroundCollet, J., & Montalescot, G. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.021 · Cited by 55
Characterization of Alterations in Diabetic Myocardial Tissue Using High Resolution MRI
Loganathan, R., Bilgen, M., Al‐Hafez, B., & Smirnova, I. V. (2005) · International journal of cardiac imaging · doi:10.1007/s10554-005-5386-6 · Cited by 50
Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options
Mytas, D. Z., Stougiannos, P. N., Zairis, M. N., Foussas, S. G., Pyrgakis, V. N., & Kyriazis, I. A. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.12.005 · Cited by 54
The double burden: type 1 diabetes and heart failure—a comprehensive review
Julián, M. T., de, A. P.-M., Julve, J., & Alonso, N. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02136-y · Cited by 55
“Autopsy samples of ventricular myocardium analyzed through traditional histological methods have revealed signs such as capillary basement membrane thickening, arteriole medial thickening, and perivascular fibrosis [37, 67, 68].”
BackgroundHan, B., Baliga, R. S., Huang, H., Giannone, P. J., & Bauer, J. A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00222.2009 · Cited by 49
Zhao, Y., Zhang, M., Wong, H. L., Tian, X., Zheng, L., Yu, X., Tian, F., Mao, K., Fan, Z.-L., Chen, P.-P., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.030 · Cited by 48
Zhang, Y., Edgley, A. J., Cox, A. J., Powell, A. K., Wang, B. H., Kompa, A. R., Stapleton, D., Zammit, S. C., Williams, S. J., Krum, H., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs011 · Cited by 45
Zheng, X., Peng, M., Li, Y., Wang, X., Lu, W., Wang, X., Shan, Y., Li, R., Gao, L., & Qiu, C. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.35736 · Cited by 43
“In diabetes cardiomyopathy, cardiomyocyte hypertrophy and microvascular abnormalities are often accompanied with cardiac fibrosis [3].”
BackgroundYang, Z., Liu, Y., Li, Z., Feng, S., Lin, S., Ge, Z., Fan, Y., Wang, Y., Wang, X., & Mao, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115011 · Cited by 50
Ng, A. C. T., Prevedello, F., Dolci, G., Roos, C. J., Djaberi, R., Bertini, M., Ewe, S. H., Allman, C., Leung, D. Y., Marsan, N. A., et al. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2018.02.012 · Cited by 48
Wang, X., Lv, H., Gu, Y., Wang, X., Cao, H., Tang, Y., Chen, H., & Huang, C. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9535-2 · Cited by 41
“ECM synthesis and deposition were significantly increased in the MI heart, and the expression of type I collagen also increased (Kawaguchi et al. 1997; Martos et al. 2007), leading to an increase in myocardial stiffness, eventually resulting in cardiac systolic and diastolic dysfunction (Boyle et…”
Saito, F., Kawaguchi, M., Izumida, J., Asakura, T., Maehara, K., & Maruyama, Y. (2003) · Diabetologia · doi:10.1007/s00125-003-1156-y · Cited by 39
Self-citationSoufy, H., Lin, T., Das, S., & Zakaria, Z. (2012) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v9i3.15 · Cited by 36
“Epidemiological studies showed that diabetes itself promoted cardiac dysfunction directly or premature atherosclerosis, indirectly (Kawaguchi et al., 1997).”
BackgroundThe role of inflammation in diabetic cardiomyopathy
Reis, F., Nunes, Soares, & Pereira (2012) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s21679 · Cited by 43
“89 Therefore, when diabetes and hypertension coexist, the DM-induced changes in the myocardial cells and capillaries lead to myocardial cell injury, interstitial fibrosis, and impairment of ventricular systolic and diastolic function.”
MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart
Liang, C., Gao, L., Liu, Y., Liu, Y., Yao, R., Li, Y., Xiao, L., Wu, L., Du, B., Huang, Z., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.059 · Cited by 34
Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes
AlBadri, A., Hashmath, Z., Oldland, G., Miller, R., Javaid, K., Syed, A. A., Ansari, B. A., Gaddam, S., Witschey, W. R. T., Akers, S. R., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0324 · Cited by 33
“Myocardial fibrosis can also lead to coronary microvascular dysfunction (36).”
BackgroundDilated Cardiomyopathies as a Cause of Congestive Heart Failure
Maisch, B., Ristić, A. D., Hufnagel, G., FUNCK, R. C., Alter, P. J., Tontsch, D., & Pankuweit, S. (2002) · Herz · doi:10.1007/s00059-002-2373-8 · Cited by 33
Complications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Plutzky, J., & Boulton, A. J. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00033-2 · Cited by 43
Guido, M. C., Marques, A. F., Tavares, E. R., de Melo, M. D. T., Salemi, V. M. C., & Maranhão, R. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5343972 · Cited by 29
“Myocyte necrosis and left ventricle (LV) fibrosis were increased in the endocardium [4, 7].”
BackgroundCapillary rarefaction: a missing link in renal and cardiovascular disease?
Steegh, F., Keijbeck, A. A., de Hoogt, P. A., Rademakers, T., Houben, A. J. H. M., Reesink, K. D., Stehouwer, C. D. A., Daemen, M. J. A. P., & Peutz‐Kootstra, C. J. (2023) · Angiogenesis · doi:10.1007/s10456-023-09883-8 · Cited by 32
“A decreased capillary density is also found in heart biopsies of individuals with insulin resistance, obesity and/or diabetes [82–85], with a thickening of the capillary basement membrane in people with diabetes [82, 86], with less pericyte coverage [87].”
Shim, C. Y., Park, S., Choi, E., Kang, S., Soo, B., Ha, J., Rim, S., Lee, H., & Chung, N. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.003 · Cited by 28
Lu, C., Zhao, Y., Zhang, M., Tian, X., & Zheng, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s99376 · Cited by 24
“29,30 Otherwise, the density of the microvessel in the diabetics is significantly decreased due to the apoptosis of endothelial cells compared to normal myocardium, so that it reduces the perfusion of the diabetic heart.”
Multimodality Imaging in Diabetic Heart Disease
Ng, A. C. T., Delgado, V., Djaberi, R., Schuijf, J. D., Boogers, M. J., Auger, D., Bertini, M., Roos, A., van der Meer, R. W., Lamb, H. J., et al. (2010) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2010.10.001 · Cited by 19
Wakisaka, M., Kamouchi, M., & Kitazono, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225668 · Cited by 19
“Subsequently, myocardial systolic dysfunction occurs, which leads to clinical HF. Myocardial and interstitial fibrosis in DCM developed independently of hypertension and coronary artery disease [21]; cardiomyocyte hypertrophy and microvascular abnormalities, such as thickening of the capillary basement membrane, have…”
BackgroundInfluentialDiabetes Mellitus And Cardiovascular Risk
Unachukwu, C., & Ofori, S. (2012) · The Internet Journal of Endocrinology · doi:10.5580/2b1d · Cited by 20
Begieneman, M. P. V., van de Goot, F. R. W., Krijnen, P. A. J., Fritz, J. M., Paulus, W. J., Spreeuwenberg, M. D., van Hinsbergh, V. W. M., & Niessen, H. W. M. (2009) · Journal of Vascular Research · doi:10.1159/000231721 · Cited by 16
“In line with this, BM thickness of capillaries was found to be significantly increased in endomyocardial biopsy specimens in patients with DM compared to control patients [”
ResultComplications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Nesto, R. W., & Boulton, A. J. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00033-x · Cited by 22
Bajraktari, G., Qirko, S., Rexhepaj, N., Bakalli, A., Beqiri, A., Elezi, S., & Ndrepepa, G. (2005) · PubMed · Cited by 15
Blood pressure and heart failure risk among diabetic patients
Zhao, W., Katzmarzyk, P. T., Horswell, R. L., Li, W., Wang, Y., Johnson, J. L., Heymsfield, S. B., Cefalu, W. T., Ryan, D. H., & Hu, G. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.051 · Cited by 17
“Themechanisms of higher blood pressure increasing the incidence of HF in diabetic patients are well documented [25,26].”
BackgroundDavid, R. B., Almeida, E. D., Cruz, L. V., Sebben, J. C., Feijó, I. P., Schmidt, K. E. S., Avena, L. M., Gottschall, C. A. M., & de Quadros, A. S. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140130 · Cited by 14
Pepe, M., Zanna, D., Cafaro, A., Marchese, A., Addabbo, F., Navarese, E. P., Napodano, M., Cecere, A., Resta, F., Paradies, V., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.015 · Cited by 15
Perspectives of nuclear diagnostic imaging in diabetic cardiomyopathy
Sasso, F. C., Rambaldi, P. F., Carbonara, O., Nasti, R., Torella, M., Rotondò, A., Torella, R., & Mansi, L. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.08.013 · Cited by 14
“The mechanisms underlying DCM are largely unknown, but may involve metabolic disturbances [4], myocardial fibrosis [5], small vessel disease [6], microcirculation abnormalities [7], cardiac autonomic neuropathy [8], and insulin resistance [9].”
BackgroundGordon, P. A. (2004) · Journal of Vascular Nursing · doi:10.1016/s1062-0303(03)00083-9 · Cited by 19
Marwick, T. H. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0049-0 · Cited by 13
“Structurally, changes in small vessels have been considered analogous to those seen in the kidney, with thickening of the basement membrane, arterial thickening, perivascular fibrosis, and reduction of capillary density [36]—changes that are potentiated by the presence of hypertension [ 37 ].”
BackgroundEffoe, V. S., McClendon, E. E., Rodriguez, C. J., Wagenknecht, L. E., Evans, G. W., Chang, P. P., & Bertoni, A. G. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.009 · Cited by 13
Guo, R., Wang, K., Song, W., Cong, T., Shang, Z., Sun, Y., & Jiang, Y. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9958-8 · Cited by 13
Breakthrough in heart failure with preserved ejection fraction: are we there yet?
Lim, S. L., & Lam, C. S. P. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.31.1.1 · Cited by 15
LEFT VENTRICULAR DIASTOLIC FILLING IN YOUNG PERSONS WITH TYPE 1 DIABETES MELLITUS
Berková, M., Opavsky, J., Berka, Z., Škraňka, V., & Salinger, J. (2003) · Biomedical Papers · doi:10.5507/bp.2003.008 · Cited by 11
Naito, J., Koretsune, Y., Sakamoto, N., Shutta, R., Yoshida, J., Yasuoka, Y., Yoshida, S., Chin, W., Kusuoka, H., & Inoue, M. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00226-6 · Cited by 11
Badran, H. M., Helmy, J. A., Ahmed, N. F., & Yacoub, M. H. (2024) · Echocardiography · doi:10.1111/echo.70048 · Cited by 11
Trotta, M. C., Herman, H., Ciceu, A., Mladin, B., Roșu, M., Lepre, C. C., Russo, M., Bácskay, I., Fenyvesi, F., Marfella, R., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1332212 · Cited by 9
Zhang, X., Tian, X., Li, P., Zhu, H., Zhou, N., Fang, Z., Yang, Y.-P., Jing, Y., & Yuan, J. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01815-4 · Cited by 9
“As the diabetes disease progresses, the microangiopathy exerts changes in the morphology and density of microvasculature [24].”
BackgroundShirbaghaee, Z., Sorenson, C. M., & Sheibani, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115333 · Cited by 11
“Additionally, PCs play a significant role in the early progression of diabetes-related cardiovascular conditions, including myocardial and interstitial fibrosis [145–147].”
Double trouble: managing diabetic emergencies in patients with heart failure
Philip, L., & Poole, R. (2018) · Practical Diabetes · doi:10.1002/pdi.2181 · Cited by 9
Systemic hemodynamics in relation to glucose tolerance: the Health 2000 Survey
Koivistoinen, T., Jula, A., Aatola, H., Kööbi, T., Moilanen, L., Lehtimäki, T. J., & Kähönen, M. A. P. (2010) · Metabolism · doi:10.1016/j.metabol.2010.05.010 · Cited by 9
“The mechanism of these adverse alterations in cardiac function is not completely understood; but it may involve myocardial cell injury and interstitial fibrosis [32], as well as slow coronary flow [33] and alterations in intracellular calcium homeostasis leading to depressed contractility [34].”
BackgroundGiant single coronary artery with terminal fistulous aneurysm: a rare entity
Adamo, L., & Adamo, M. (2006) · Heart · doi:10.1136/hrt.2006.091009 · Cited by 6
Diabetic cardiomyopathy—What do we know about it?
Haq, M. A. U., Mutha, V., Rudd, N., & Wong, C. Y. (2013) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2013.35a005 · Cited by 6
“There is also enhanced thickening of capillary basement membrane, myocellular atrophy and hypertrophy with myocardial and interstitial fibrosis, which further reduce myocardial function [24-26].”
BackgroundChanges of cardiac function in diabetic dogs
Vichit, P., Rungsipipat, A., & Surachetpong, S. D. (2018) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2018.08.001 · Cited by 6
Stratmann, B., Stork, I., & Tschoepe, D. (2008) · Der Internist · doi:10.1007/s00108-008-2047-6 · Cited by 5
No reflow : quels facteurs prédictifs ?
Chettibi, M., Benghezel, S., Bertal, S., Nedjar, R., Bouraghda, M. A., & Bouafia, M. T. C. (2015) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2015.09.059 · Cited by 7
Dietary Choline Deprivation Exacerbates Cardiomyopathy in Streptozotocin-Induced Diabetic Adult Rats
Al-Humadi, A. W., Strilakou, A. A., Al‐Humadi, H., Al‐Saigh, R., Agapitos, E., Mourouzis, I. S., Al‐Najim, W., & Liapi, C. A. (2021) · Diabetology · doi:10.3390/diabetology2040017 · Cited by 4
Asker, S. A., Mazroa, S. A., & Abdel-Malek, H. (2010) · The Egyptian Journal of Histology · doi:10.1097/00767537-201003000-00010 · Cited by 4
Hamid, K. M. A., & Hussein, O. A. (2015) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000470655.35872.32 · Cited by 4
Enfermedad del músculo cardíaco en la diabetes mellitus
Fernández-Fúnez, Á., Cabrera, R., & Hernández, A. (2000) · Medicina Clínica · doi:10.1016/s0025-7753(00)71453-9 · Cited by 4
Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis
Ballestero, S. B., Yttergren, S. T., Hahn, M., Rosenkilde, M. B., Jensen, D. M., Christensen, M. S., Thisted, L., Holmberg, H. L., Teixeira, G., Biering‐Sørensen, T., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70217 · Cited by 4
“Semaglutide reduces HF symptoms in obesity-associated HFpEF and diminishes major adverse cardiovascular events risk and mortality in both HFpEF and HF with reduced EF (Deanfield et al., 2024; Kosiborod et al., 2023, 2024).”
Diastolic Disturbances in Diabetes Mellitus
Marwick, T. H. (2008) · Springer eBooks · doi:10.1007/978-1-84628-891-3_19 · Cited by 3
Tangvarasittichai, S. (2009) · Siriraj Medical Journal/San Sirirat · Cited by 3
Moreno, R., Hernández‐Antolín, R., Alfonso, F., & Macaya, C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00166-2 · Cited by 3
Zhang, L., Huang, S., Li, X., Yang, Z., Ye, P., Sun, R., Xu, H., Xu, R., Zhang, M., Liu, Y., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02757-x · Cited by 3
“Autopsy studies of ventricular myocardial samples have confirmed the presence of microvascular abnormalities in diabetic patients, including capillary basement membrane thickening, arteriolar intimal thickening, and increased perivascular fibrosis [17, 18].”
Biomarkers of Myocardial Fibrosis in Diabetes, Echocardiography, and Magnetic Resonance Imaging
Madsen, P. L. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_45-1 · Cited by 2
Gaol, A. Y. D. L., Sijabat, M., Saragih, J., Prasetya, E., Ningsih, A., & Sipahutar, H. (2024) · International Conference on Innovation in Education, Science and Culture (ICIESC) · doi:10.4108/eai.24-10-2023.2342144 · Cited by 2
Clinical modifiers for heart failure following myocardial infarction
Anavekar, N. S., & Anavekar, N. S. (2005) · Current Heart Failure Reports · doi:10.1007/bf02696646 · Cited by 2
“These include increased collagen content, myocardial fibrosis, and hypertrophy [ 15 ], which may explain the tendency of diabetics to develop diastolic dysfunction and smaller ventricular cavities more than nondiabetic subjects [16].”
Background
Metadata
- Authors
- Kawaguchi, M., Techigawara, M., Ishihata, T., Asakura, T., Saito, F., Maehara, K., & Maruyama, Y.
- Affiliations
- Fukushima Medical University (JP)
- Fuji Heavy Industries Health Insurance Society Ota Memorial Hospital (JP)
- ORCID
- Maruyama, Yukio
- Venue
- Heart and Vessels
- Published
- 1997-11
- Volume
- 12
- Issue
- 6
- Pages
- 267-274
- ISSN
- 0910-8327 (ISSN-L)
- 1615-2573
- OpenAlex
- W2081538288
- Cited by
- 118
- References
- 28
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 8 · 2017: 2 · 2016: 3 · 2015: 7 · 2014: 6 · 2013: 4 · 2012: 8
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Heart and Vessels (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- diabetic cardiomyopathy, diabetes mellitus, hypertension, myocardial ultrastructure, endomyocardial biopsy, capillary basement membrane thickening, interstitial fibrosis, left ventricular function, myocardial cell injury
- MeSH terms
- Adult, Aged, Aged, 80 and over, Biopsy, Capillaries, Cardiomyopathy, Hypertrophic, Diabetes Mellitus, Coloring Agents, Electrocardiography, Endocardium, Female, Humans, Hypertension, Male, Middle Aged, Myocardial Contraction, Stroke Volume, Tolonium Chloride, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.